Faurecia S.E.
Faurecia S.E. (FAURY) Financial Performance & Income Statement Overview
Review Faurecia S.E. (FAURY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Faurecia S.E. (FAURY) Income Statement & Financial Overview
Analyze Faurecia S.E.’s FAURY earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $13.44B | $13.53B | $6.81B | $6.81B |
| Cost of Revenue | $11.65B | $11.72B | $11.91B | $5.91B |
| Gross Profit | $1.79B | $1.82B | -$5.10B | $906.45M |
| Gross Profit Ratio | $0.13 | $0.13 | -$0.75 | $0.13 |
| R&D Expenses | $847.70M | $829.10M | $416.40M | $384.65M |
| SG&A Expenses | $649.80M | $640.20M | $622.70M | $317.15M |
| Operating Expenses | $1.18B | $1.21B | $1.04B | $576.65M |
| Total Costs & Expenses | $12.84B | $12.93B | $12.95B | $6.48B |
| Interest Income | $59.10M | $140.60M | $49.70M | $128.15M |
| Interest Expense | $304.40M | $640.40M | $306.00M | $0.00 |
| Depreciation & Amortization | $552.60M | $564.10M | $698.70M | $349.60M |
| EBITDA | $1.14B | $1.16B | $1.38B | $616.50M |
| EBITDA Ratio | $0.09 | $0.09 | $0.20 | $0.09 |
| Operating Income | $602.50M | $607.00M | $678.20M | $328.50M |
| Operating Income Ratio | $0.04 | $0.04 | $0.10 | $0.05 |
| Other Income/Expenses (Net) | -$550.30M | -$448.10M | -$476.55M | -$126.85M |
| Income Before Tax | $52.20M | $158.90M | $201.65M | $201.65M |
| Income Before Tax Ratio | $0.004 | $0.01 | $0.03 | $0.03 |
| Income Tax Expense | $176.10M | $59.20M | $58.35M | $58.35M |
| Net Income | -$190.00M | $4.80M | $96.90M | $108.80M |
| Net Income Ratio | -$0.01 | $0.00 | $0.01 | $0.02 |
| EPS | -$0.96 | $0.02 | $0.62 | $0.55 |
| Diluted EPS | -$0.96 | $0.02 | $0.55 | $0.55 |
| Weighted Avg Shares Outstanding | $197.31M | $240.00M | $176.14M | $197.78M |
| Weighted Avg Shares Outstanding (Diluted) | $197.31M | $197.36M | $197.56M | $197.56M |
Over the past four quarters, Faurecia S.E. demonstrated steady revenue growth, increasing from $6.81B in Q3 2023 to $13.44B in Q4 2024. Operating income reached $602.50M in Q4 2024, maintaining a consistent 4% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.14B, reflecting operational efficiency. Net income dropped to -$190.00M, with EPS at -$0.96. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan